Evidence map›Paper›PMID 21559341›Full record

ArticlePloS one2011

Pancreatic beta cells synthesize neuropeptide Y and can rapidly release peptide co-transmitters.

Matthew D Whim

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. β-Cell Maturation and Identity in Health and Disease.International journal of molecular sciences · 2019
    Review
  6. Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions.Clinical medicine insights. Endocrinology and diabetes · 2019
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. DPP4 in Diabetes.Frontiers in immunology · 2015
    Review
  13. Article
  14. Article
  15. Neuropeptide y gates a stress-induced, long-lasting plasticity in the sympathetic nervous system.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  16. Article
  17. Neuropeptide Y and somatostatin inhibit insulin secretion through different mechanisms.American journal of physiology. Endocrinology and metabolism · 2013
    Article
  18. Review
  19. Review
  20. Deconstructing pancreas developmental biology.Cold Spring Harbor perspectives in biology · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Matthew D WhimDepartment of Cell Biology and Anatomy, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America. mwhim@lsuhsc.edu
Louisiana State University Health Sciences Center New Orleans · US

Funding

Neuropeptide Y and the Control of Catecholamine Secretion from the Adrenal GlandR01DK080441 · NIDDK · PENNSYLVANIA STATE UNIVERSITY, THE · PI WHIM, MATTHEW · 2009 to 2012
$897k
Neuropeptide Y and the Control of Catecholamine Secretion from the Adrenal GlandR56DK080441 · NIDDK · PENNSYLVANIA STATE UNIVERSITY, THE · PI WHIM, MATTHEW · 2008 to 2008
$103k
NIDDK NIH HHS DK080441NIDDK NIH HHS R01 DK080441NIDDK NIH HHS R56 DK080441
6 · The paper itself

Abstract

backgroundIn addition to polypeptide hormones, pancreatic endocrine cells synthesize a variety of bioactive molecules including classical transmitters and neuropeptides. While these co-transmitters are thought to play a role in regulating hormone release little is known about how their secretion is regulated. Here I investigate the synthesis and release of neuropeptide Y from pancreatic beta cells. METHODOLOGY/PRINCIPAL

findingsNPY appears to be an authentic co-transmitter in neonatal, but not adult, beta cells because (1) early in mouse post-natal development, many beta cells are NPY-immunoreactive whereas no staining is observed in beta cells from NPY knockout mice; (2) GFP-expressing islet cells from an NPY(GFP) transgenic mouse are insulin-ir; (3) single cell RT-PCR experiments confirm that the NPY(GFP) cells contain insulin mRNA, a marker of beta cells. The NPY-immunoreactivity previously reported in alpha and delta cells is therefore likely to be due to the presence of NPY-related peptides. INS-1 cells, a beta cell line, are also NPY-ir and contain NPY mRNA. Using the FMRFamide tagging technique, NPY secretion was monitored from INS-1 beta cells with high temporal resolution. Peptide release was evoked by brief depolarizations and was potentiated by activators of adenylate cyclase and protein kinase A. Following a transient depolarization, NPY-containing dense core granules fused with the cell membrane and discharged their contents within a few milliseconds.

conclusionsThese results indicate that after birth, NPY expression in pancreatic islets is restricted to neonatal beta cells. The presence of NPY suggests that peptide co-transmitters could mediate rapid paracrine or autocrine signaling within the endocrine pancreas. The FMRFamide tagging technique may be useful in studying the release of other putative islet co-transmitters in real time.

Indexed as

Gene Expression RegulationAnimalsCell LineCytoplasmElectrophysiologyFMRFamideGreen Fluorescent ProteinsImmunohistochemistryInsulin-Secreting CellsKineticsMiceMice, Inbred C57BLMicroscopy, FluorescenceNeuropeptide YPeptidesReverse Transcriptase Polymerase Chain ReactionFMRFamideGreen Fluorescent ProteinsNeuropeptide YPeptides

Identifiers

PMID21559341
PMCPMC3084883
OpenAlexW2026261063

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.